Filter
1133
Text search:
drug
susceptibility
Featured
152
273
Language
Document type
581
211
200
59
34
19
15
10
2
1
1
Countries
59
42
32
30
28
25
24
23
19
18
18
16
15
14
14
14
14
10
9
9
9
8
7
7
6
6
6
6
6
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
363
137
58
25
21
19
15
Toolboxes
338
181
57
43
40
38
27
22
18
14
14
14
12
11
11
11
10
10
7
7
5
4
3
2
Revised National Tuberculosis Control Programme
3rd edition
Training for staff working at DR-TB management centres.
Training modules
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
2nd edition
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra
...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients w
...
HIV & AIDS Treatment in Practice No.202
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
